Search by Drug Name or NDC

    NDC 73070-0200-11 Insulin Aspart Protamine and Insulin Aspart 100 [iU]/mL Details

    Insulin Aspart Protamine and Insulin Aspart 100 [iU]/mL

    Insulin Aspart Protamine and Insulin Aspart is a SUBCUTANEOUS INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk Pharma, Inc.. The primary component is INSULIN ASPART.

    Product Information

    NDC 73070-0200
    Product ID 73070-200_ec67820c-4008-4894-b933-34b28704221d
    Associated GPIs 27104070001820
    GCN Sequence Number 051718
    GCN Sequence Number Description insulin aspart prot/insuln asp VIAL 70-30/ML SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 19057
    HICL Sequence Number 023400
    HICL Sequence Number Description INSULIN ASPART PROTAMINE HUMAN/INSULIN ASPART
    Brand/Generic Generic
    Proprietary Name Insulin Aspart Protamine and Insulin Aspart
    Proprietary Name Suffix Mix 70/30
    Non-Proprietary Name insulin aspart
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SUSPENSION
    Route SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN ASPART
    Labeler Name Novo Nordisk Pharma, Inc.
    Pharmaceutical Class Insulin Analog [EPC], Insulin [CS]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA021172
    Listing Certified Through 2024-12-31

    Package

    NDC 73070-0200-11 (73070020011)

    NDC Package Code 73070-200-11
    Billing NDC 73070020011
    Package 1 VIAL, GLASS in 1 CARTON (73070-200-11) / 10 mL in 1 VIAL, GLASS
    Marketing Start Date 2019-09-10
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 6.93098
    Pricing Unit ML
    Effective Date 2024-01-01
    NDC Description INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 5, 6
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis